Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ahmed K. B. Aljohani"'
Autor:
Ahmed K. B. Aljohani, Waheed Ali Zaki El Zaloa, Mohamed Alswah, Mohamed A. Seleem, Mohamed M. Elsebaei, Ashraf H. Bayoumi, Ahmed M. El-Morsy, Mohammed Almaghrabi, Aeshah A. Awaji, Ali Hammad, Marwa Alsulaimany, Hany E. A. Ahmed
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 19, p 15026 (2023)
Phenylpyrazolo[3,4-d]pyrimidine is considered a milestone scaffold known to possess various biological activities such as antiparasitic, antifungal, antimicrobial, and antiproliferative activities. In addition, the urgent need for selective and poten
Externí odkaz:
https://doaj.org/article/0a56b615b6774e4a8133efe02789d5b2
Autor:
Abdulrahim A. Alzain, Rua M. Mukhtar, Nihal Abdelmoniem, Tagyedeen H. Shoaib, Wadah Osman, Marwa Alsulaimany, Ahmed K. B. Aljohani, Sara A. Almadani, Baiaan H. Alsaadi, Maryam M. Althubyani, Shaimaa G. A. Mohamed, Gamal A. Mohamed, Sabrin R. M. Ibrahim
Publikováno v:
Molecules, Vol 28, Iss 16, p 6003 (2023)
Oxidative stress plays a significant role in the development of cancer. Inhibiting the protein-protein interaction (PPI) between Keap1 and Nrf2 offers a promising strategy to activate the Nrf2 antioxidant pathway, which is normally suppressed by the
Externí odkaz:
https://doaj.org/article/65a8bc4f5bee40058f97d5d001b6c453
Autor:
Alistair K. Brown, Ahmed K. B. Aljohani, Fatimah M. A. Alsalem, Joseph L. Broadhead, Jason H. Gill, Yucheng Lu, Jonathan D. Sellars
Publikováno v:
Molecules, Vol 25, Iss 10, p 2387 (2020)
Discovery and development of new therapeutic options for the treatment of Mycobacterium tuberculosis (Mtb) infection, particularly drug-resistant strains, are urgently required to tackle the global burden of this disease. Herein, we reported the synt
Externí odkaz:
https://doaj.org/article/6f5b4d3328244cd9bcad0406864618ce
Autor:
Alistair K. Brown, Ahmed K. B. Aljohani, Jason H. Gill, Patrick G. Steel, Jonathan D. Sellars
Publikováno v:
Molecules, Vol 24, Iss 4, p 811 (2019)
Discovery and development of new therapeutic options for the treatment of Mycobacterium tuberculosis (Mtb) infection are desperately needed to tackle the continuing global burden of this disease and the efficacy and cost limitations associated with c
Externí odkaz:
https://doaj.org/article/38ab9c03995546de90e93ad297aa20cd
Autor:
Zehbah A. Al‐Ahmed, Seraj Omar Alzahrani, Ahmed K. B. AlJohani, Najla A. Obaid, Kholood Alkhamis, Alaa M. Alqahtani, Nashwa M. El‐Metwaly
Publikováno v:
Applied Organometallic Chemistry. 37
Autor:
Azizah M. Malebari, Hany E. A. Ahmed, Saleh K. Ihmaid, Abdelsattar M. Omar, Yosra A. Muhammad, Sultan S. Althagfan, Naif Aljuhani, Abdel-Aziz A. A. El-Sayed, Ahmed H. Halawa, Heba M. El-Tahir, Safaa A. Turkistani, Mohammed Almaghrabi, Ahmed K. B. Aljohani, Ahmed M. El-Agrody, Hamada S. Abulkhair
Publikováno v:
Bioorganic chemistry. 130
COVID-19 and associated substantial inflammations continue to threaten humankind triggering death worldwide. So, the development of new effective antiviral and anti-inflammatory medications is a major scientific goal. Pyranopyrazoles have occupied a
Autor:
Ahmed K. B. Aljohani, Alistair K. Brown, Fatimah M A Alsalem, Joseph L Broadhead, Yucheng Lu, Jonathan D. Sellars, Jason H. Gill
Publikováno v:
Molecules
Volume 25
Issue 10
Molecules, Vol 25, Iss 2387, p 2387 (2020)
Volume 25
Issue 10
Molecules, Vol 25, Iss 2387, p 2387 (2020)
Discovery and development of new therapeutic options for the treatment of Mycobacterium tuberculosis (Mtb) infection, particularly drug-resistant strains, are urgently required to tackle the global burden of this disease. Herein, we reported the synt